Skip to content

Impact of Therapist Change on Dropout in a Naturalistic Sample of Inpatients With Borderline Pathology Receiving DBT

Impact of Therapist Change After Initial Contact and Traumatic Burden on Dropout in a Naturalistic Sample of Inpatients With Borderline Pathology Receiving Dialectical Behavior Therapy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03018639
Enrollment
89
Registered
2017-01-12
Start date
2012-12-31
Completion date
2016-08-31
Last updated
2017-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Borderline Personality Disorder, Dropout, PostTraumatic Stress Disorder, Psychotherapy

Brief summary

Participants with Borderline pathology (≥ 3 DSM-IV-criteria) receiving an inpatient Dialectical Behavior Therapy (DBT) program completed a quality assurance questionnaire set assessing demographic information and pretreatment psychopathology during the days of their inpatient stay. Beyond that, changes of therapists were documented.

Interventions

BEHAVIORALDialectical Behavior Therapy

DBT is a cognitive-behavioral treatment program that was developed to treat suicidal Patients with BPD (Linehan, 1993).

Sponsors

Evangelisches Krankenhaus Bielefeld gGmbH
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* three or more criteria for BPD as defined by DSM-IV (Borderline Personality characteristics; BPC)

Exclusion criteria

* inability to contract and consent, * other severe mental disorders (bipolar disorder, acute psychosis), * current alcohol, * illicit or not prescribed drug use, * simultaneous participation in other treatment studies, * pregnancy or breastfeeding, * an inability to negotiate a non-suicide agreement, * ongoing traumatic contact with the perpetrator, and * a Body Mass Index \< 16.5.

Design outcomes

Primary

MeasureTime frame
Dropout10 weeks

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 9, 2026